This year the AAL Forum will be held on September 23-25 in Aarhus, Denmark. Join us in Aarhus and meet some of the most prestigious experts talk about their work of active and healthy ageing. Speakers are experts in their sectors and will share their ideas about tech, policy, business and social perspective that will surely enrich our knowledge landscape.
The percentage of old people in the population will rise, in part because of successful health policies. However, a longer life has problems of its own. Many ZonMw programmes are directed towards improving the health and welfare of elderly people. Our underlying conviction is that elderly people should be able to do things their own way, and as independently as possible, with the support of their social networks and – where necessary – professional help.
ZonMw works to achieve this through research, innovation, and attention for the dissemination and practical application of knowledge.
Learn more about co-creation and commercialisation of ICT solutions for older adults in the publication ‘The impact of AAL in the Netherlands’. The publication shows what the European Active & Assisted Living (AAL) programme has delivered for the Netherlands until now. Often in the words of those who directly involved. Their stories provide an inspiring glimpse into the future everyday lives of older adults.
The Joint Programming Initiative (JPI) More Years, Better Lives (MYBL) seeks to enhance coordination and collaboration between European and national research programmes related to demographic change in order to provide solutions for the upcoming challenges and to make use of the potential of societal change in Europe.
The Active and Assisted Living Joint Programme (AAL JP) is designed to foster the development of innovative technological/ICT-based products, services and systems to meet the needs of our ageing society and compensate for the expected staff shortages in the care sector. ZonMw is responsible for the implementation of AAL JP in the Netherlands.
In Europe, as well as globally, we face a number of societal challenges that no country or region can tackle alone. Addressing these so-called Grand Societal Challenges efficiently and effectively requires combined efforts and new ways of collaboration between countries. Today, there are 10 Joint Programming Initiatives (JPIs) with the aim to tackle Grand Societal Challenges. In a new brochure they explain the benefits of participating in a Joint Programming Initiative.
ZonMw selected two challenges for ‘proof of concept’ projects of Create2Solve. With Create2Solve, ZonMw makes funding available to research organisations and SMEs (small and medium-sized enterprises) for the development of animal-free innovations within the program More Knowledge with Fewer Animals. This call for demand-driven innovations is now open for proposals. On 22 August, ZonMw will organise a webinar for any interested parties who want to...
On Friday 21 June, Monique den Boer from the Princess Máxima Center received the second ZonMw Open Science Boost. Radjesh Manna, director of programmes at ZonMw, handed her the prize during a surprise visit to Utrecht. Monique den Boer, Professor of Molecular Pediatric Leukemia, together with her research group, made a big contribution to the objectives of open science: responsive, transparent, and responsible science. With this boost, ZonMw...
The AAL Call 2019 focused on “Sustainable Smart Solutions for Ageing well” was closed on 24 May. The Call, which is the 12th one published by the Programme since its inception in 2008, received 82 applications, out of which 57 were collaborative projects and 25 were small collaborative projects. Following the central eligibility check, 81 applications were admitted to the evaluation.
Research within the following research areas is eligible for funding in this round:
Studies on how to prevent the acquisition and / or transmission of antibacterial resistant bacteria, or ABR genes in different environments according to One Health e.g., patients, hospitals, farms, nature, etc.
Studies that support appropriate (use of) diagnostics.
Studies that support new or improved applications for antibiotics and alternatives to antibiotics.
Studies on optimising dosage and prudent use of antibiotics.